Percentage of total, granulocyte/macrophage, and T cells ofPax5−/− origin
Months . | % of total cells* . | granulocytes/macrophages . | % T cells of total cells1-153 . | ||||
---|---|---|---|---|---|---|---|
% of total cells† . | % of total Gr/Mac‡ . | ||||||
3 . | 4 . | 3 . | 4 . | 4 . | 3 . | 4 . | |
Mouse | |||||||
1 | 42.5 | 73.6 | 15.5 | 65.7 | 76.0 | 28.5 | 7.1 |
2 | 59.0 | 84.7 | 47.3 | 64.2 | 87.6 | 9.7 | 18.6 |
3 | 13.6 | 9.2 | 1.5 | 3 | 2.1 | 11.5 | 7.2 |
4 | 8.2 | 2.5 | ND | ND | ND | 6.9 | 2.5 |
5 | 25.1 | 16.4 | 10.9 | 10.2 | 15.2 | 15.1 | 6.2 |
6 | 8.4 | 10.3 | 1.0 | 2.0 | 2.0 | 8.0 | 8.0 |
7 | 3.3 | 4.4 | ND | ND | ND | 3.1 | 3.3 |
8 | 8.5 | 8.1 | ND | ND | ND | 6.7 | 5.9 |
9 | 40.4 | 75.2 | 42.2 | 64.2 | 84.3 | 18.2 | 16.2 |
10 | 75.0 | 87.0 | 69.1 | 74.5 | 92.9 | 8.1 | 12.7 |
Months . | % of total cells* . | granulocytes/macrophages . | % T cells of total cells1-153 . | ||||
---|---|---|---|---|---|---|---|
% of total cells† . | % of total Gr/Mac‡ . | ||||||
3 . | 4 . | 3 . | 4 . | 4 . | 3 . | 4 . | |
Mouse | |||||||
1 | 42.5 | 73.6 | 15.5 | 65.7 | 76.0 | 28.5 | 7.1 |
2 | 59.0 | 84.7 | 47.3 | 64.2 | 87.6 | 9.7 | 18.6 |
3 | 13.6 | 9.2 | 1.5 | 3 | 2.1 | 11.5 | 7.2 |
4 | 8.2 | 2.5 | ND | ND | ND | 6.9 | 2.5 |
5 | 25.1 | 16.4 | 10.9 | 10.2 | 15.2 | 15.1 | 6.2 |
6 | 8.4 | 10.3 | 1.0 | 2.0 | 2.0 | 8.0 | 8.0 |
7 | 3.3 | 4.4 | ND | ND | ND | 3.1 | 3.3 |
8 | 8.5 | 8.1 | ND | ND | ND | 6.7 | 5.9 |
9 | 40.4 | 75.2 | 42.2 | 64.2 | 84.3 | 18.2 | 16.2 |
10 | 75.0 | 87.0 | 69.1 | 74.5 | 92.9 | 8.1 | 12.7 |
ND indicates not detectable.
Percentage of blood nucleated cells ofPax5−/− origin as determined by H-2b- and GFP-expression.
Percentage of blood nucleated cells ofPax5−/− origin expressing Gr-1 and Mac-1.
Percentage of Gr-1 and Mac-1 expressing cells ofPax5−/− origin.
Percentage of blood nucleated cells ofPax5−/− origin expressing CD3.